Brief: Piramal Pharma Sept Quarter Consol Net Loss 992.2 Million Rupees
05/11/2025 15:35
Nov 5 (Reuters) - Piramal Pharma Ltd PIRM.NS: SEPT QUARTER CONSOL NET LOSS 992.2 MILLION RUPEES SEPT QUARTER CONSOL REVENUE FROM OPERATIONS 20.44 BILLION RUPEES Source text: [ID:] Further company coverage: PIRM.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma Receives Permanent Revocation Of Closure Order For Dahej Site
Brief: Piramal Pharma Solutions Announces Partnership With Botanix To Support Drug Substance Development
Brief: Piramal Pharma Announces Successful Closure Of Us FDA Inspection At Digwal Facility
India's Piramal Pharma eyes complex drug demand for earnings boost, chair says
Brief: Piramal Pharma Says Closure Of US FDA Inspection At Manufacturing Facility At Lexington